Recommendations for standards regarding preclinical neuroprotective and restorative drug development by Feinklestein, S, Fisher, M, Furland, A, Goldstein, L, Gorelick, P, Kaste, M, Lees, K, Traystman, R, Albers, G, Anwer, U, Ashwood, T, Barone, F, Basta, S, Bogousslavsky, J, Buchan, A, Cady, W, Chan, P, Clemens, J, Cox, B, Craddock, R, Cramer, S, del Zoppo, G, Dielrich, W, Elliott, P, Faden, A

Effects of alteplase for acute stroke according to criteria defining the EU and US marketing authorizations: individual-patient-data meta-analysis of randomized trials by Hacke, W, Lyden, P, Emberson, J, Baigent, C, Blackwell, L, Albers, G, Bluhmki, E, Brott, T, Cohen, G, Davis, SM, Donnan, GA, Grotta, JC, Howard, G, Kaste, M, Koga, M, von Kummer, R, Lansberg, MG, Lindley, RI, Olivot, J-M, Parsons, M, Sandercock, PAG, Toni, D, Toyoda, K, Wahlgren, N, Wardlaw, JM, Whiteley, WN, del Zoppo, G, Lees, KR

Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis by Whiteley, W, Emberson, J, Lees, K, Blackwell, L, Albers, G, Bluhmki, E, Brott, T, Cohen, G, Davis, S, Donnan, G, Grotta, J, Howard, G, Kaste, M, Koga, M, von Kummer, R, Lansberg, M, Lindley, R, Lyden, P, Olivot, J, Parsons, M, Toni, D, Toyoda, K, Wahlgren, N, Wardlaw, J, Del Zoppo, G, Sandercock, P, Hacke, W, Baigent, C